Any e-cig use among young smokers increases odds of smoking in late adolescence

While it is well-established that youth who initiate nicotine use with e-cigarettes are more likely to start smoking and that e-cigarettes are expanding nicotine addiction, no one had examined whether e-cigarette use promotes continued smoking among youth. Now Brian Kelly and colleagues have published a well-done paper addressing that question: E-cigarette use among early adolescentContinue reading “Any e-cig use among young smokers increases odds of smoking in late adolescence”

The 6-state Juul settlement includes some stronger provisions than earlier settlements

The latest settlements between six states (California, Colorado, District of Columbia, Illinois, Massachusetts, New Mexico and New York) and the District of Columbia and Juul, announced on April 11, 2023, mostly follows the earlier North Carolina settlement, but does include some stronger provisions, particularly compared to the earlier 33 state settlement. This summary is basedContinue reading “The 6-state Juul settlement includes some stronger provisions than earlier settlements”

Detailed changing use patterns of e-cigs and cigs shows harm enhancement for adults and youth

Until the advent of e-cigarettes nearly 20 years ago tobacco use patterns were pretty stable.  Almost everyone who smoked tobacco smoked cigarettes with a few people smoking cigars.  And some people used smokeless tobacco.  With the advent of e-cigarettes and other new tobacco products, this situation has become much more complicated, particularly since some inContinue reading “Detailed changing use patterns of e-cigs and cigs shows harm enhancement for adults and youth”

FDA inches ahead by denying marketing order for RJR Vuse Solo menthol

FDA has continued to deny marketing authorization for menthol e-cigarettes with its March 17, 2023 announcement that it had denied marketing authorization for two RJR Vuse Solo menthol cartridges. This action follows FDA denials for RJR Vuse Ciro menthol and JTI Logic menthol e-cigarettes. While FDA does not make its detailed analysis public for marketingContinue reading “FDA inches ahead by denying marketing order for RJR Vuse Solo menthol”

Youth E-cig use much lower in countries that prohibit e-cigs

A new paper, Electronic cigarettes use and ‘dual use’ among the youth in 75 countries: estimates from Global Youth Tobacco Surveys (2014–2019) shows that countries that prohibit the sale of e-cigarettes, like Thailand and Brazil, have much lower levels of youth cigarette use than countries that allow them and have laws to restrict sales toContinue reading “Youth E-cig use much lower in countries that prohibit e-cigs”

Three new papers detail FDA errors in authorizing Vuse Solo

Last week Tobacco Control published two peer reviewed scientific critiques of FDA’s authorization for RJ Reynolds to sell Vuse Solo e-cigarettes as well as a commentary on the two papers.  Both papers recommend FDA exercise its authority to withdraw authorization to sell Vuse Solo and the commentary because FDA did not demonstrate that marketing VuseContinue reading “Three new papers detail FDA errors in authorizing Vuse Solo”

FDA pushes back date for finishing PMTAs (again)

The convenience store trade publication CSP reported that the FDA has pushed the anticipated date for finishing making decisions on premarket tobacco product applications (PMTAs) — mostly e-cigarettes — again, this time to the end of 2023. According to CSP, The Food and Drug Administration is going to need until the end of 2023 toContinue reading “FDA pushes back date for finishing PMTAs (again)”

UCSF Tobacco Center Billion Lives Symposium available for online viewing

As in past years, the symposium is archived and available to watch for free here. This is the program: Keynote Panel: 20 Years of the Industry Documents: Past, Present and Future: Presentations by Faculty and Postdoctoral Scholars: Closing Remarks, Chris Shaffer, MS, UCSF Assistant Vice Chancellor and University Librarian The last several years’ symposia areContinue reading “UCSF Tobacco Center Billion Lives Symposium available for online viewing”

FDA denies marketing authorization for two RJR Vuse menthol ecigs

Following the same logic FDA used to deny marketing authorization of JTI Logic menthol e-cigarettes, FDA has denied authorization for RJR to sell menthol versions of its Vuse Vibe Tank Menthol 3.0% and the Vuse Ciro Cartridge Menthol 1.5% e-cigs. While FDA does not post the Marketing Denial Orders, Center for Tobacco Products Director Brian KingContinue reading “FDA denies marketing authorization for two RJR Vuse menthol ecigs”